A randomized phase II study of paclitaxel with carboplatin ± amifostine as first line treatment in advanced ovarian carcinoma
Authors:
- A.M.E. BosABA.M.E. Bos
- M. SchaapveldMSM. Schaapveld
- C.A.M. de SwartCSC.A.M. de Swart
- H. de GraafHGH. de Graaf
- A.G.J. van der ZeeAZA.G.J. van der Zee
- H.M. BoezenHBH.M. Boezen
- E.G.E. de VriesEVE.G.E. de Vries
- P.H.B. WillemsePWP.H.B. Willemse
- 1 April 2005
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 97 (1) , 60-67
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patientsAnnals of Oncology, 2003
- Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung CancerJournal of Clinical Oncology, 2003
- Protective Effect of Amifostine Against Toxicity of Paclitaxel and Carboplatin in Non-small Cell Lung Cancer: A Single Center Randomized StudyMedical Oncology, 2003
- Exploratory Phase III Study of Paclitaxel and Cisplatin Versus Paclitaxel and Carboplatin in Advanced Ovarian CancerJournal of Clinical Oncology, 2000
- Phase II study of the combination carboplatin and paclitaxel in patients with ovarian cancerAnnals of Oncology, 1997
- Epithelial ovarian carcinomaThe Lancet, 1997
- Amifostine pretreatment for protection against cyclophosphamide-induced and cisplatin-induced toxicities: results of a randomized control trial in patients with advanced ovarian cancer.Journal of Clinical Oncology, 1996
- Carboplatin and paclitaxel in ovarian carcinoma: a phase I study of the Gynecologic Oncology Group.Journal of Clinical Oncology, 1996
- Carboplatin dosage: prospective evaluation of a simple formula based on renal function.Journal of Clinical Oncology, 1989
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976